Journal article
Outcomes of stage I/II follicular lymphoma in the PET era: An international study from the Australian Lymphoma Alliance
JWD Tobin, G Rule, K Colvin, L Calvente, D Hodgson, S Bell, C Dunduru, J Gallo, ES Tsang, X Tan, J Wong, J Pearce, R Campbell, S Tneh, S Shorten, M Ng, T Cochrane, CS Tam, E Abro, E Hawkes Show all
Blood Advances | ELSEVIER | Published : 2019
Abstract
Management practices in early-stage (I/II) follicular lymphoma (FL) are variable and include radiation (RT), systemic therapy, or combined modality therapy (CMT). There is a paucity of data regarding maintenance rituximab in this cohort. We conducted an international retrospective study of patients with newly diagnosed early-stage FL staged with positron emission tomography (PET)–computed tomography and bone marrow biopsy. Three hundred sixty-five patients (stage I, n 5 221), median age 63 years, treated from 2005-2017 were included, with a median follow-up of 45 months. Management included watchful waiting (WW; n 5 85) and active treatment (n 5 280). The latter consisted of RT alone (n 5 17..
View full abstract